CT2019/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INTRACRANIAL REVASCULARISATION DEVICES – PAY PER USE
TED · 385191-2026Award noticeawardedNo deadline given
Value
Estimated€3,552,777 · 3,552,777 EUR
Awarded€3,468,486 · 3,468,486 EUR
WinnerE.J. BUSUTTIL LIMITED | A.M. Mangion Ltd
Who already wins at this buyer
Firms with recorded awards from Department of Contracts in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| E.J. BUSUTTIL LIMITED | 7 | €2,953,933 | 2026-06-25 |
| V.J. Salomone Pharma Limited | 4 | €11,867,887 | 2026-06-24 |
| Drugsales Ltd | 3 | €2,659,922 | 2026-06-11 |
| Mint Health Limited | 3 | €1,145,101 | 2026-06-09 |
| Evolve Ltd. | 2 | €1,613,879 | 2026-06-24 |
Full buyer profile: what Department of Contracts buys and who wins it →
CPV codes
33190000 Medical equipment & pharmaceuticals33111710 Medical equipment & pharmaceuticals33141200 Medical equipment & pharmaceuticalsDescription
CT2019/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INTRACRANIAL REVASCULARISATION DEVICES – PAY PER USE
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-27 | CT2101/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF NEEDLES FOR INTRA OSSEOUS VASCULAR ACCESS | Department of Contracts MT | 93% |
| 2026-07-02 | CT2262/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF RE-ENTRY CATHETERS | Department of Contracts MT | 92% |
| 2026-06-29 | CT2145/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF ENTERIC PATHOGEN ASSAYS WITH EQUIPMENT ON LOAN | Department of Contracts MT | 92% |
| 2026-07-23 | CT2296/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF PLASMA KALLIKREIN INHIBITOR | Department of Contracts MT | 92% |
| 2026-05-08 | CT2058/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF IFOBT AND CALPROTECTIN TESTING ON A PAY-PER-USE BASIS | Department of Contracts MT | 92% |
| 2026-07-23 | CT2294/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF DIAMORPHINE HYDROCHLORIDE INJECTIONS | Department of Contracts MT | 92% |